1. October 2025 - 30. September 2030
PERFEKT develops a compact, cost-efficient analysis system for decentralized infection diagnostics. The device performs all test steps automatically, from prepared sample to result, and can be used in labs or directly on-site. Assays target Chlamydia, Staphylococcus aureus/MRSA, and Legionella for infection detection, typing, and resistance analysis. Combining DNA and protein-based tests, the system supports surveillance, outbreak prevention and advances InfectoGnostics technologies toward practical application.